HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Gardaí search for missing Dublin woman Lucy Donovan

Families arrive at Áras an Uachtaráin for tree-lighting ceremony

Poet John Montague dies aged 87

Seanad may have problem in temporary move to National Museum


Today's Stories

Therapist slipped in restaurant after dress tangled with high heels

Treasure trove of artifacts found under Cork street

Revenue probes minister turned car salesman Ivor Callely

In the shadow of gunmen: Unsolved shootings in Cork

Lifestyle

Pantomime review: Cinderella, Cork Opera House

Fair City: Behind the scenes at Carrigstown

Big read: Home to the world’s greatest restaurant

Ask Audrey has been sorting out Cork people for years

More From The Irish Examiner